These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2144213)

  • 21. [The phase I study of 99mTc-MAG3 injection, a dynamic renal imaging agent--evaluation of its safety and biodistribution in normal volunteers].
    Ikekubo K; Hino M; Ito H; Yamamoto K; Torizuka K
    Kaku Igaku; 1993 May; 30(5):507-16. PubMed ID: 8336410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99Tcm-MAG3: in vitro stability and in vivo behaviour at different times after preparation.
    Millar AM; Wilkinson AG; McAteer E; Best JJ
    Nucl Med Commun; 1990 Jun; 11(6):405-12. PubMed ID: 2143569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of the renal function and imaging agent 99mTc-MAG3 starting from S-unprotected mercaptoacetyltriglycine.
    Noll B; Johannsen B; May K; Spies H
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):899-901. PubMed ID: 1321100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvement in nuclear medicine diagnosis of kidney function using 99m technetium mercaptoacetyltriglycine (MAG3)].
    Erpenbach K; Ebert A; Wieler H
    Urologe A; 1991 Mar; 30(2):99-105. PubMed ID: 1829284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment.
    Misra M; Pradhan PK; De K; Chandra S; Das BK
    Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [99m-Technetium-mercaptoacetyltriglycine (MAG3) for the demonstration of the kidney changes following extracorporeal shockwave lithotripsy. A prospective study of 117 patients].
    Schaub T; Witsch U; el-Damanhoury H; Nägele-Wöhrle B; Hahn K
    Rofo; 1992 Oct; 157(4):338-43. PubMed ID: 1391835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
    Kengen RA; Meijer S; Beekhuis H; Piers DA
    J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition.
    Dondi M; Monetti N; Fanti S; Marchetta F; Corbelli C; Zagni P; De Fabritis A; Losinno F; Levorato M; Zuccalá A
    J Nucl Med; 1991 Mar; 32(3):424-8. PubMed ID: 1826024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Parametric representation of kidney function using 99mTc-mercaptoacetyltriglycine (MAG3)].
    Szabó Z; Kutkuhn B; Georgescu G; Mecklenbeck W; Suatmadji A; Vosberg H
    Nuklearmedizin; 1989 Jun; 28(3):73-83. PubMed ID: 2525703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical usefulness of 99mTc-MAG3--a multicenter phase III study].
    Ishii K; Ishibashi A; Torizuka K
    Kaku Igaku; 1993 May; 30(5):517-28. PubMed ID: 8336411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 99Tcm-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with 99Tcm-MAG3.
    Kibar M; Noyan A; Anarat A
    Nucl Med Commun; 1997 Jan; 18(1):44-52. PubMed ID: 9061700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
    Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
    J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of the four isomers of 99mTc-cysteinyltriglycine, an amino substituted derivative of 99mTc-MAG3.
    Cleynhens B; Adriaens P; Boonen C; Vanbilloen H; Van Nerom C; Verbruggen AM
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):69-74. PubMed ID: 7632771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.